Get the Stockscreener App
248.49
7.30%
16.87
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $248.49, with a volume of 731.28K.
It is up +7.30% in the last 24 hours and down -11.50% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$231.62
Open:
$235.37
24h Volume:
731.28K
Relative Volume:
0.91
Market Cap:
$17.88B
Revenue:
$2.96B
Net Income/Loss:
$487.70M
P/E Ratio:
37.22
EPS:
6.6758
Net Cash Flow:
$344.00M
1W Performance:
+7.53%
1M Performance:
-11.50%
6M Performance:
+4.74%
1Y Performance:
-24.79%
1-Day Range:
$233.50
$248.71
1-Week Range:
$228.00
$248.71
52-Week Range:
$187.43
$332.47
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
248.51 | 16.66B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
489.21 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
208.32 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
271.03 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.32 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.50 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
WST: Integrated syringe system accelerates development and simplifies compliance for pharma teams - TradingView
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? - Finviz
West Pharma Sets February Earnings Reveal as Investors Await 2025 Results - MyChesCo
Selecting A Prefillable Syringe System With Confidence - Bioprocess Online
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 8 - Med Device Online
West Pharmaceutical Services drives innovation in cancer treatment packaging - Traders Union
West Pharmaceutical Services Inc (WST) Shares Up 4.04% on Feb 4 - GuruFocus
NovaPure® Syringe Plungers eBook: Chapter 2: Component Design And Manufacture - Med Device Online
Evercore ISI Lowers Price Target for West Pharmaceutical Services (WST) | WST Stock News - GuruFocus
West Pharmaceutical Services (BIT:1WST) Price Target Decreased by 11.92% to 278.11 - Nasdaq
Truist Financial Corp Has $7.64 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Volume Report: Is West Pharmaceutical Services Inc part of any major index2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New York State Common Retirement Fund Has $23.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Valuation Check After Recent Share Price Pressure - Yahoo Finance
Published on: 2026-01-31 17:32:53 - Mfd.ru
Assessing West Pharmaceutical Services (WST) After A 32% One-Year Share Price Pullback - Sahm
West Pharmaceutical Services Inc (WST) Shares Gap Down to $225.5 on Jan 30 - GuruFocus
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Is West Pharmaceutical (WST) Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat? - Sahm
West to Host Fourth-Quarter and Full-Year 2025 Conference Call - BioSpace
Kinston marks anniversary of West Pharmaceutical Services explosion - WCTI
Is West Pharmaceutical Services Inc. a good ESG investmentPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru
West Pharmaceutical Services, Inc. $WST Shares Sold by Bank of New York Mellon Corp - MarketBeat
Process Safety Quiz: Dust Explosions and Fires - ChemistryViews
Prefilled Syringe Barrels Market Set for Dynamic Development - openPR.com
West to sell SmartDose 3.5mL system to AbbVie in $112.5M deal - MSN
West Pharmaceutical Services taps Robert McMahon as CFO - MSN
Ex-Dividend Reminder: West Pharmaceutical Services, Heritage Financial and Entegris - Nasdaq
Assessing West Pharmaceutical (WST) Valuation After Bullish Earnings Outlook And Demand Strength - Sahm
West Pharmaceutical Services (WST) Stock Analysis: A 46% Upside Potential That Investors Can't Ignore - DirectorsTalk Interviews
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? - Benzinga
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - MyChesCo
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Profit Review: What is Know Labs Incs market positionJuly 2025 Earnings & Weekly High Return Stock Forecasts - baoquankhu1.vn
Is West Pharmaceutical Services Stock Built to Withstand More Downside? - Trefis
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio - Sahm
Analysis Recap: Can AROW grow without external funding2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack - sharewise.com
West Pharmaceutical Services Becomes Oversold (WST) - Nasdaq
Bull Run: Is West Pharmaceutical Services Inc trading at a discountM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Market Outlook: Is West Pharmaceutical Services Inc stock showing strong momentumEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
Performance Recap: Whats the outlook for West Pharmaceutical Services Incs sector2025 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - yourwyominglink.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):